Kawartha Lakes records 1st seasonal lab-confirmed influenza case
Local health unit encourages residents to take preventative steps, including receiving vaccination, to protect community ...
The American Journal of Managed Care4h
Impact of RSV on Hospitalizations in US Adults Prior to Vaccine Introduction
Respiratory syncytial virus (RSV) caused significant hospitalizations and severe outcomes in adults, especially those aged 75 ...
Digital Journal21h
Chikungunya and vaccines: Combatting mosquito diseases
The researchers have evaluated the effectiveness of the assay using herpes simplex virus (HSV-2), respiratory syncytial virus ...
中国日报网1d
First bivalent mRNA vaccine candidate against RSV goes under clinical trial
The world's first bivalent mRNA vaccine candidate against respiratory syncytial virus, or RSV, kicked off Phase I clinical ...
News Medical2d
Early RSV vaccination in pregnancy provides best protection for newborns
Current guidelines recommend that pregnant people receive a vaccine against respiratory syncytial virus (RSV)-;which typically causes mild, cold-like symptoms in most adults but can be deadly for ...
Study reveals best timing for getting the RSV vaccine during pregnancy to protect newborns
Current guidelines recommend that pregnant people receive a vaccine against respiratory syncytial virus (RSV)—which typically ...
MedPage Today3d
Which High-Risk Patients Should Get the RSV Vaccine?
The CDC recommends a single dose of any FDA-approved respiratory syncytial virus (RSV) vaccine for all adults ages 75 years ...
MedPage Today3d
Real-World Data on the RSV Vaccine for Older Adults
Regarding hospitalizations among immunocompetent older adults, vaccine effectiveness was 83% for the GSK vaccine and 73% for ...
Moderna’s mRESVIA vaccine gains Health Canada approval
Moderna has received Health Canada's approval for its respiratory syncytial virus messenger ribonucleic acid (mRNA) vaccine ...
Daily3d
Moderna bags Health Canada nod for RSV vaccine for adults aged 60 years and older
Cambridge: Moderna, Inc. has announced Health Canada has approved mRESVIA (Respiratory Syncytial Virus mRNA vaccine) for active immunization for the prevention of lower respiratory tract disease ...
Daily3d
GSK RSV vaccine approved in Canada for adults aged 50-59 at increased risk
Mississauga: GSK's AREXVY (respiratory syncytial virus vaccine - recombinant, AS01E adjuvanted) has been approved in Canada ...
Pharmabiz3d
Health Canada approves Moderna’s RSV vaccine, mRESVIA for adults aged 60 years and older
Health Canada approves Moderna’s RSV vaccine, mRESVIA for adults aged 60 years and older: Cambridge, Massachusetts Monday, November 11, 2024, 12:00 Hrs [IST] Moderna, Inc., a le ...